Esperion Therapeutics shares owned by Principal Financial Group
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Principal Financial Group
from 13F filings
Historical chart of Principal Financial Group investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by Principal Financial Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Esperion Therapeutics by Principal Financial Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $504k | 190k | 2.65 |
| 2025-06-30 | $387k | 393k | 0.98 |
| 2025-03-31 | $19k | 13k | 1.44 |
| 2024-12-31 | $27k | 12k | 2.20 |
| 2024-09-30 | $25k | 15k | 1.65 |
| 2024-06-30 | $45k | 20k | 2.22 |
| 2024-03-31 | $78k | 29k | 2.68 |
| 2023-12-31 | $101k | 34k | 2.99 |
| 2023-09-30 | $34k | 34k | 0.98 |
| 2023-06-30 | $44k | 32k | 1.39 |
| 2023-03-31 | $31k | 19k | 1.59 |
| 2022-12-31 | $129k | 21k | 6.23 |
| 2022-09-30 | $114k | 17k | 6.75 |
| 2022-06-30 | $108k | 17k | 6.33 |
| 2022-03-31 | $49k | 11k | 4.67 |
| 2020-09-30 | $207k | 5.6k | 37.24 |
| 2020-06-30 | $518k | 10k | 51.23 |
| 2019-12-31 | $236k | 4.0k | 59.51 |
| 2018-03-31 | $334k | 4.6k | 72.33 |
| 2017-12-31 | $274k | 4.2k | 65.72 |